{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:54:38Z","timestamp":1787813678899,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Cardiovascular Association-Access fund","award":["2021-CCA-ACCESS-142"],"award-info":[{"award-number":["2021-CCA-ACCESS-142"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100279"],"award-info":[{"award-number":["82100279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["tsqn202312327"],"award-info":[{"award-number":["tsqn202312327"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88375-9","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:09:45Z","timestamp":1738246185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mendelian randomization analysis does not support a causal influence between lipoprotein(A) and immune-mediated inflammatory diseases"],"prefix":"10.1038","volume":"15","author":[{"given":"Yun","family":"Ti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"88375_CR1","doi-asserted-by":"publisher","unstructured":"Marcovina, S. M. & Koschinsky, M. L. Lipoprotein(a) as a risk factor for coronary artery disease. Am. J. Cardiol. 82, 57U\u201366U. https:\/\/doi.org\/10.1016\/s0002-9149(98)00954-0  (1998).","DOI":"10.1016\/s0002-9149(98)00954-0"},{"key":"88375_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/10408363.2016.1188055","volume":"53","author":"K Kotani","year":"2016","unstructured":"Kotani, K., Serban, M. C., Penson, P., Lippi, G. & Banach, M. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - some answers and still many questions. Crit. Rev. Clin. Lab. Sci. 53, 370\u2013378. https:\/\/doi.org\/10.1080\/10408363.2016.1188055 (2016).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"88375_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou, S. et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Jama 302, 412\u2013423. https:\/\/doi.org\/10.1001\/jama.2009.1063 (2009).","journal-title":"Jama"},{"key":"88375_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.pcad.2020.06.002","volume":"63","author":"RR Guddeti","year":"2020","unstructured":"Guddeti, R. R. et al. Lipoprotein(a) and calcific aortic valve stenosis: a systematic review. Prog Cardiovasc. Dis. 63, 496\u2013502. https:\/\/doi.org\/10.1016\/j.pcad.2020.06.002 (2020).","journal-title":"Prog Cardiovasc. Dis."},{"key":"88375_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jacc.2022.02.018","volume":"79","author":"P Mohammadi-Shemirani","year":"2022","unstructured":"Mohammadi-Shemirani, P. et al. Elevated lipoprotein(a) and risk of Atrial Fibrillation: an observational and mendelian randomization study. J. Am. Coll. Cardiol. 79, 1579\u20131590. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.018 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88375_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jchf.2015.08.006","volume":"4","author":"PR Kamstrup","year":"2016","unstructured":"Kamstrup, P. R. & Nordestgaard, B. G. Elevated lipoprotein(a) levels, LPA risk genotypes, and increased risk of Heart failure in the General Population. JACC Heart Fail. 4, 78\u201387. https:\/\/doi.org\/10.1016\/j.jchf.2015.08.006 (2016).","journal-title":"JACC Heart Fail."},{"key":"88375_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/circulationaha.116.020838","volume":"134","author":"FM van der Valk","year":"2016","unstructured":"van der Valk, F. M. et al. Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation 134, 611\u2013624. https:\/\/doi.org\/10.1161\/circulationaha.116.020838 (2016).","journal-title":"Circulation"},{"key":"88375_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0167-4889(03)00083-1","volume":"1642","author":"C Buechler","year":"2003","unstructured":"Buechler, C. et al. Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes. Biochim. Biophys. Acta. 1642, 25\u201331. https:\/\/doi.org\/10.1016\/s0167-4889(03)00083-1 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"88375_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1194\/jlr.M036343","volume":"54","author":"P Wiesner","year":"2013","unstructured":"Wiesner, P. et al. MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma. J. Lipid Res. 54, 1877\u20131883. https:\/\/doi.org\/10.1194\/jlr.M036343 (2013).","journal-title":"J. Lipid Res."},{"key":"88375_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1194\/jlr.R071233","volume":"57","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard, B. G. & Langsted, A. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J. Lipid Res. 57, 1953\u20131975. https:\/\/doi.org\/10.1194\/jlr.R071233 (2016).","journal-title":"J. Lipid Res."},{"key":"88375_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.17305\/bb.2023.8992","volume":"23","author":"D Tomic Naglic","year":"2023","unstructured":"Tomic Naglic, D., Manojlovic, M., Pejakovic, S., Stepanovic, K. & Prodanovic Simeunovic, J. Lipoprotein(a): role in atherosclerosis and new treatment options. Biomol. Biomed. 23, 575\u2013583. https:\/\/doi.org\/10.17305\/bb.2023.8992 (2023).","journal-title":"Biomol. Biomed."},{"key":"88375_CR12","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.4103\/0975-7406.155767","volume":"7","author":"KP Govindan","year":"2015","unstructured":"Govindan, K. P., Basha, S., Ramesh, V., Kumar, C. N. & Swathi, S. A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects. J. Pharm. Bioallied Sci. 7, S22\u201325. https:\/\/doi.org\/10.4103\/0975-7406.155767 (2015).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"88375_CR13","first-page":"220","volume":"21","author":"EF Borba","year":"1994","unstructured":"Borba, E. F. et al. Lipoprotein(a) levels in systemic lupus erythematosus. J. Rheumatol. 21, 220\u2013223 (1994).","journal-title":"J. Rheumatol."},{"key":"88375_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","volume":"25","author":"D Dursuno\u011flu","year":"2005","unstructured":"Dursuno\u011flu, D. et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol. Int. 25, 241\u2013245. https:\/\/doi.org\/10.1007\/s00296-004-0438-0 (2005).","journal-title":"Rheumatol. Int."},{"key":"88375_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jacl.2017.02.018","volume":"11","author":"C Garc\u00eda-G\u00f3mez","year":"2017","unstructured":"Garc\u00eda-G\u00f3mez, C. et al. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: results from the CARdiovascular in rheuMAtology study project. J. Clin. Lipidol. 11, 749\u2013756e743. https:\/\/doi.org\/10.1016\/j.jacl.2017.02.018 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"88375_CR16","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/00042737-200112000-00004","volume":"13","author":"IE Koutroubakis","year":"2001","unstructured":"Koutroubakis, I. E. et al. Increased levels of lipoprotein (a) in Crohn\u2019s disease: a relation to thrombosis? Eur. J. Gastroenterol. Hepatol. 13, 1415\u20131419. https:\/\/doi.org\/10.1097\/00042737-200112000-00004 (2001).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"88375_CR17","doi-asserted-by":"publisher","unstructured":"Missala, I., Kassner, U. & Steinhagen-Thiessen, E. A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune diseases and atherosclerosis. Int. J. Rheumatol. 2012 (480784). https:\/\/doi.org\/10.1155\/2012\/480784 (2012).","DOI":"10.1155\/2012\/480784"},{"key":"88375_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1681\/asn.v61110","volume":"6","author":"F Kronenberg","year":"1995","unstructured":"Kronenberg, F. et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol. 6, 110\u2013120. https:\/\/doi.org\/10.1681\/asn.v61110 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"88375_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0272-6386(12)80389-1","volume":"23","author":"J Thillet","year":"1994","unstructured":"Thillet, J. et al. Am. J. Kidney Dis. 23 620\u2013621 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"88375_CR20","doi-asserted-by":"publisher","first-page":"ofz301","DOI":"10.1093\/ofid\/ofz301","volume":"6","author":"M Van den Hof","year":"2019","unstructured":"Van den Hof, M. et al. Elevated lipoprotein(a) in perinatally HIV-Infected Children compared with healthy ethnicity-matched controls. Open. Forum Infect. Dis. 6, ofz301. https:\/\/doi.org\/10.1093\/ofid\/ofz301 (2019).","journal-title":"Open. Forum Infect. Dis."},{"key":"88375_CR21","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian Randomization Jama 318, 1925\u20131926 https:\/\/doi.org\/10.1001\/jama.2017.17219 (2017).","journal-title":"Mendelian Randomization Jama"},{"key":"88375_CR22","doi-asserted-by":"publisher","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362, k601. https:\/\/doi.org\/10.1136\/bmj.k601 (2018).","DOI":"10.1136\/bmj.k601"},{"key":"88375_CR23","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson, S. C., Butterworth, A. S. & Burgess, S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur. Heart J. 44, 4913\u20134924. https:\/\/doi.org\/10.1093\/eurheartj\/ehad736 (2023).","journal-title":"Eur. Heart J."},{"key":"88375_CR24","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081 (2017).","journal-title":"PLoS Genet."},{"key":"88375_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess, S. & Thompson, S. G. Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol. 181, 251\u2013260. https:\/\/doi.org\/10.1093\/aje\/kwu283 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"88375_CR26","doi-asserted-by":"publisher","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers. 2 https:\/\/doi.org\/10.1038\/s43586-021-00092-5 (2022).","DOI":"10.1038\/s43586-021-00092-5"},{"key":"88375_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","volume":"43","author":"G Trynka","year":"2011","unstructured":"Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193\u20131201. https:\/\/doi.org\/10.1038\/ng.998 (2011).","journal-title":"Nat. Genet."},{"key":"88375_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979\u2013986. https:\/\/doi.org\/10.1038\/ng.3359 (2015).","journal-title":"Nat. Genet."},{"key":"88375_CR29","doi-asserted-by":"publisher","unstructured":"Multiple sclerosis genomic. Map implicates peripheral immune cells and microglia in susceptibility. Science 365 https:\/\/doi.org\/10.1126\/science.aav7188 (2019).","DOI":"10.1126\/science.aav7188"},{"key":"88375_CR30","doi-asserted-by":"publisher","unstructured":"Stuart, P. E. et al. Transethnic analysis of psoriasis susceptibility in South asians and europeans enhances fine-mapping in the MHC and genomewide. HGG Adv. 3 https:\/\/doi.org\/10.1016\/j.xhgg.2021.100069 (2022).","DOI":"10.1016\/j.xhgg.2021.100069"},{"key":"88375_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376\u2013381. https:\/\/doi.org\/10.1038\/nature12873 (2014).","journal-title":"Nature"},{"key":"88375_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457\u20131464. https:\/\/doi.org\/10.1038\/ng.3434 (2015).","journal-title":"Nat. Genet."},{"key":"88375_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou, J. et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594, 398\u2013402. https:\/\/doi.org\/10.1038\/s41586-021-03552-w (2021).","journal-title":"Nature"},{"key":"88375_CR34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","volume":"53","author":"AR Barton","year":"2021","unstructured":"Barton, A. R., Sherman, M. A., Mukamel, R. E. & Loh, P. R. Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses. Nat. Genet. 53, 1260\u20131269. https:\/\/doi.org\/10.1038\/s41588-021-00892-1 (2021).","journal-title":"Nat. Genet."},{"key":"88375_CR35","doi-asserted-by":"publisher","first-page":"e1003062","DOI":"10.1371\/journal.pmed.1003062","volume":"17","author":"TG Richardson","year":"2020","unstructured":"Richardson, T. G. et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis. PLoS Med. 17, e1003062. https:\/\/doi.org\/10.1371\/journal.pmed.1003062 (2020).","journal-title":"PLoS Med."},{"key":"88375_CR36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden, J. et al. Improving the accuracy of two-sample summary-data mendelian randomization: moving beyond the NOME assumption. Int. J. Epidemiol. 48, 728\u2013742. https:\/\/doi.org\/10.1093\/ije\/dyy258 (2019).","journal-title":"Int. J. Epidemiol."},{"key":"88375_CR37","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u201398. https:\/\/doi.org\/10.1093\/hmg\/ddu328 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"88375_CR38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce, B. L. & Burgess, S. Efficient design for mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am. J. Epidemiol. 178, 1177\u20131184. https:\/\/doi.org\/10.1093\/aje\/kwt084 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"88375_CR39","doi-asserted-by":"publisher","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7 https:\/\/doi.org\/10.7554\/eLife.34408 (2018).","DOI":"10.7554\/eLife.34408"},{"key":"88375_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob, E. A. W. & Burgess, S. A comparison of robust mendelian randomization methods using summary data. Genet. Epidemiol. 44, 313\u2013329. https:\/\/doi.org\/10.1002\/gepi.22295 (2020).","journal-title":"Genet. Epidemiol."},{"key":"88375_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965 (2016).","journal-title":"Genet. Epidemiol."},{"key":"88375_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"88375_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/ede.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Bowden, J., Fall, T., Ingelsson, E. & Thompson, S. G. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology 28, 30\u201342. https:\/\/doi.org\/10.1097\/ede.0000000000000559 (2017).","journal-title":"Epidemiology"},{"key":"88375_CR44","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3899\/jrheum.080928","volume":"36","author":"C Garc\u00eda-G\u00f3mez","year":"2009","unstructured":"Garc\u00eda-G\u00f3mez, C. et al. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis. J. Rheumatol. 36, 1365\u20131370. https:\/\/doi.org\/10.3899\/jrheum.080928 (2009).","journal-title":"J. Rheumatol."},{"key":"88375_CR45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s100670200127","volume":"21","author":"RA Sari","year":"2002","unstructured":"Sari, R. A., Polat, M. F., Taysi, S., Bakan, E. & Capo\u011flu, I. Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus. Clin. Rheumatol. 21, 520\u2013524. https:\/\/doi.org\/10.1007\/s100670200127 (2002).","journal-title":"Clin. Rheumatol."},{"key":"88375_CR46","doi-asserted-by":"publisher","first-page":"e030651","DOI":"10.1136\/bmjopen-2019-030651","volume":"9","author":"S Holm","year":"2019","unstructured":"Holm, S. et al. Levels of lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study. BMJ Open. 9, e030651. https:\/\/doi.org\/10.1136\/bmjopen-2019-030651 (2019).","journal-title":"BMJ Open."},{"key":"88375_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","volume":"67","author":"RC Hoogeveen","year":"2021","unstructured":"Hoogeveen, R. C. & Ballantyne, C. M. Residual Cardiovascular risk at low LDL: remnants, Lipoprotein(a), and inflammation. Clin. Chem. 67, 143\u2013153. https:\/\/doi.org\/10.1093\/clinchem\/hvaa252 (2021).","journal-title":"Clin. Chem."},{"key":"88375_CR48","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/cvr\/cvab100","volume":"118","author":"DI Swerdlow","year":"2022","unstructured":"Swerdlow, D. I. et al. Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics. Cardiovasc. Res. 118, 1218\u20131231. https:\/\/doi.org\/10.1093\/cvr\/cvab100 (2022).","journal-title":"Cardiovasc. Res."},{"key":"88375_CR49","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cca.2011.03.029","volume":"412","author":"C Zhang","year":"2011","unstructured":"Zhang, C. et al. Increased serum levels of \u03b2\u2082-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis. Clin. Chim. Acta. 412, 1332\u20131336. https:\/\/doi.org\/10.1016\/j.cca.2011.03.029 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"88375_CR50","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.cca.2012.05.006","volume":"413","author":"C Zhang","year":"2012","unstructured":"Zhang, C. et al. Elevated serum \u03b2\u2082-GPI-Lp(a) complexes levels in children with nephrotic syndrome. Clin. Chim. Acta. 413, 1657\u20131660. https:\/\/doi.org\/10.1016\/j.cca.2012.05.006 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"88375_CR51","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1529-0131(199912)42:12<2606::AID-ANR14>3.0.CO;2-X","volume":"42","author":"FI Romero","year":"1999","unstructured":"Romero, F. I. et al. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum. 42, 2606\u20132611 (1999).","journal-title":"Arthritis Rheum."},{"key":"88375_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0021-9150(94)90106-6","volume":"108","author":"GH Dahl\u00e9n","year":"1994","unstructured":"Dahl\u00e9n, G. H. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108, 111\u2013126. https:\/\/doi.org\/10.1016\/0021-9150(94)90106-6 (1994).","journal-title":"Atherosclerosis"},{"key":"88375_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","volume":"9","author":"MG Levin","year":"2024","unstructured":"Levin, M. G. & Burgess, S. Mendelian randomization as a Tool for Cardiovascular Research: a review. JAMA Cardiol. 9, 79\u201389. https:\/\/doi.org\/10.1001\/jamacardio.2023.4115 (2024).","journal-title":"JAMA Cardiol."},{"key":"88375_CR54","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A. & Timpson, N. Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034 (2008).","journal-title":"Stat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88375-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:09:51Z","timestamp":1738246191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88375"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88375-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4878166\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3834"}}